153 related articles for article (PubMed ID: 32444889)
21. 2017 Version of LI-RADS for CT and MR Imaging: An Update.
Elsayes KM; Hooker JC; Agrons MM; Kielar AZ; Tang A; Fowler KJ; Chernyak V; Bashir MR; Kono Y; Do RK; Mitchell DG; Kamaya A; Hecht EM; Sirlin CB
Radiographics; 2017; 37(7):1994-2017. PubMed ID: 29131761
[TBL] [Abstract][Full Text] [Related]
22. Validation of organ procurement and transplant network (OPTN)/united network for organ sharing (UNOS) criteria for imaging diagnosis of hepatocellular carcinoma.
Fowler KJ; Karimova EJ; Arauz AR; Saad NE; Brunt EM; Chapman WC; Heiken JP
Transplantation; 2013 Jun; 95(12):1506-11. PubMed ID: 23778569
[TBL] [Abstract][Full Text] [Related]
23. Interreader Reliability of LI-RADS Version 2014 Algorithm and Imaging Features for Diagnosis of Hepatocellular Carcinoma: A Large International Multireader Study.
Fowler KJ; Tang A; Santillan C; Bhargavan-Chatfield M; Heiken J; Jha RC; Weinreb J; Hussain H; Mitchell DG; Bashir MR; Costa EAC; Cunha GM; Coombs L; Wolfson T; Gamst AC; Brancatelli G; Yeh B; Sirlin CB
Radiology; 2018 Jan; 286(1):173-185. PubMed ID: 29091751
[TBL] [Abstract][Full Text] [Related]
24. Accuracy of the diagnostic evaluation of hepatocellular carcinoma with LI-RADS.
Liu W; Qin J; Guo R; Xie S; Jiang H; Wang X; Kang Z; Wang J; Shan H
Acta Radiol; 2018 Feb; 59(2):140-146. PubMed ID: 28648125
[TBL] [Abstract][Full Text] [Related]
25. Diagnostic performance of MR for hepatocellular carcinoma based on LI-RADS v2018, compared with v2017.
Ren AH; Zhao PF; Yang DW; Du JB; Wang ZC; Yang ZH
J Magn Reson Imaging; 2019 Sep; 50(3):746-755. PubMed ID: 30648327
[TBL] [Abstract][Full Text] [Related]
26. Improving Patient Care by Incorporation of Multidisciplinary Breast Radiology-Pathology Correlation Conference.
Prakash S; Venkataraman S; Slanetz PJ; Dialani V; Fein-Zachary V; Littlehale N; Mehta TS
Can Assoc Radiol J; 2016 May; 67(2):122-9. PubMed ID: 26632099
[TBL] [Abstract][Full Text] [Related]
27. Nonstandardized Terminology to Describe Focal Liver Lesions in Patients at Risk for Hepatocellular Carcinoma: Implications Regarding Clinical Communication.
Corwin MT; Lee AY; Fananapazir G; Loehfelm TW; Sarkar S; Sirlin CB
AJR Am J Roentgenol; 2018 Jan; 210(1):85-90. PubMed ID: 29023148
[TBL] [Abstract][Full Text] [Related]
28. Liver Imaging Reporting and Data System Category 5: MRI Predictors of Microvascular Invasion and Recurrence After Hepatectomy for Hepatocellular Carcinoma.
Chen J; Zhou J; Kuang S; Zhang Y; Xie S; He B; Deng Y; Yang H; Shan Q; Wu J; Sirlin CB; Wang J
AJR Am J Roentgenol; 2019 Oct; 213(4):821-830. PubMed ID: 31120791
[No Abstract] [Full Text] [Related]
29. Evidence Supporting LI-RADS Major Features for CT- and MR Imaging-based Diagnosis of Hepatocellular Carcinoma: A Systematic Review.
Tang A; Bashir MR; Corwin MT; Cruite I; Dietrich CF; Do RKG; Ehman EC; Fowler KJ; Hussain HK; Jha RC; Karam AR; Mamidipalli A; Marks RM; Mitchell DG; Morgan TA; Ohliger MA; Shah A; Vu KN; Sirlin CB;
Radiology; 2018 Jan; 286(1):29-48. PubMed ID: 29166245
[TBL] [Abstract][Full Text] [Related]
30. Optimal lexicon of gadoxetic acid-enhanced magnetic resonance imaging for the diagnosis of hepatocellular carcinoma modified from LI-RADS.
Hwang SH; Park S; Han K; Choi JY; Park YN; Park MS
Abdom Radiol (NY); 2019 Sep; 44(9):3078-3088. PubMed ID: 31165907
[TBL] [Abstract][Full Text] [Related]
31. Locoregional therapies for hepatocellular carcinoma and the new LI-RADS treatment response algorithm.
Kielar A; Fowler KJ; Lewis S; Yaghmai V; Miller FH; Yarmohammadi H; Kim C; Chernyak V; Yokoo T; Meyer J; Newton I; Do RK
Abdom Radiol (NY); 2018 Jan; 43(1):218-230. PubMed ID: 28780679
[TBL] [Abstract][Full Text] [Related]
32. Accuracy of the Liver Imaging Reporting and Data System in Computed Tomography and Magnetic Resonance Image Analysis of Hepatocellular Carcinoma or Overall Malignancy-A Systematic Review.
van der Pol CB; Lim CS; Sirlin CB; McGrath TA; Salameh JP; Bashir MR; Tang A; Singal AG; Costa AF; Fowler K; McInnes MDF
Gastroenterology; 2019 Mar; 156(4):976-986. PubMed ID: 30445016
[TBL] [Abstract][Full Text] [Related]
33. Liver Imaging Reporting and Data System: Patient Outcomes for Category 4 and 5 Nodules.
Choi SH; Byun JH; Lim YS; Lee SJ; Kim SY; Won HJ; Shin YM; Kim PN
Radiology; 2018 May; 287(2):515-524. PubMed ID: 29457964
[TBL] [Abstract][Full Text] [Related]
34. LI-RADS for MR Imaging Diagnosis of Hepatocellular Carcinoma: Performance of Major and Ancillary Features.
Cerny M; Bergeron C; Billiard JS; Murphy-Lavallée J; Olivié D; Bérubé J; Fan B; Castel H; Turcotte S; Perreault P; Chagnon M; Tang A
Radiology; 2018 Jul; 288(1):118-128. PubMed ID: 29634435
[TBL] [Abstract][Full Text] [Related]
35. A radiogenomic analysis of hepatocellular carcinoma: association between fractional allelic imbalance rate index and the liver imaging reporting and data system (LI-RADS) categories and features.
Furlan A; Almusa O; Yu RK; Sagreiya H; Borhani AA; Bae KT; Marsh JW
Br J Radiol; 2018 Jun; 91(1086):20170962. PubMed ID: 29565672
[TBL] [Abstract][Full Text] [Related]
36. Inter-operator variability and source of errors in tumour response assessment for hepatocellular carcinoma treated with sorafenib.
Tovoli F; Renzulli M; Negrini G; Brocchi S; Ferrarini A; Andreone A; Benevento F; Golfieri R; Morselli-Labate AM; Mastroroberto M; Badea RI; Piscaglia F
Eur Radiol; 2018 Sep; 28(9):3611-3620. PubMed ID: 29633000
[TBL] [Abstract][Full Text] [Related]
37. Man or machine? Prospective comparison of the version 2018 EASL, LI-RADS criteria and a radiomics model to diagnose hepatocellular carcinoma.
Jiang H; Liu X; Chen J; Wei Y; Lee JM; Cao L; Wu Y; Duan T; Li X; Ma L; Song B
Cancer Imaging; 2019 Dec; 19(1):84. PubMed ID: 31806050
[TBL] [Abstract][Full Text] [Related]
38. LI-RADS major features: CT, MRI with extracellular agents, and MRI with hepatobiliary agents.
Santillan C; Fowler K; Kono Y; Chernyak V
Abdom Radiol (NY); 2018 Jan; 43(1):75-81. PubMed ID: 28828680
[TBL] [Abstract][Full Text] [Related]
39. Ancillary features in the Liver Imaging Reporting and Data System: how to improve diagnosis of hepatocellular carcinoma ≤ 3 cm on magnetic resonance imaging.
Kang JH; Choi SH; Byun JH; Kim DH; Lee SJ; Kim SY; Won HJ; Shin YM; Kim PN
Eur Radiol; 2020 May; 30(5):2881-2889. PubMed ID: 32020399
[TBL] [Abstract][Full Text] [Related]
40. Differentiation of Hepatocellular Carcinoma from Other Hepatic Malignancies in Patients at Risk: Diagnostic Performance of the Liver Imaging Reporting and Data System Version 2014.
Fraum TJ; Tsai R; Rohe E; Ludwig DR; Salter A; Nalbantoglu I; Heiken JP; Fowler KJ
Radiology; 2018 Jan; 286(1):158-172. PubMed ID: 28853673
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]